Phage-induced protection against lethal bacterial reinfection
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2423286122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Yikun Xing und 8 weiteren Autor:innen. Beteiligte Einrichtung: TAILOR Labs, Baylor College of Medicine, Houston, TX 77030. Hauptthemen laut MEDLINE: Phage Therapy, Bacteriophages, Reinfection, Bacterial Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS, Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (Kleberg Foundation).
Abstract (Originalsprache)
Bacteriophages, or phages, are viruses that target and infect bacteria. Due to a worldwide rise in antimicrobial resistance (AMR), phages have been proposed as a promising alternative to antibiotics for the treatment of resistant bacterial infections. Up to this point in history, phage use in preclinical animal studies, clinical trials, and emergency-use compassionate care cases has centered around the original observation from 1915 showing phage as lytic agent, and thus a treatment that kills bacteria. Here, we describe an activity associated with phage therapy that extends beyond lytic activity that results in long-term protection against reinfection. This activity is potent, providing almost complete protection against a second lethal infection for animals treated with phage therapy. The activity also reduced infection burden an astounding billion-fold over the control. Reinfection protection requires phage lytic killing of its target bacterium but is independent of additional phage therapy. The effect is not driven by phage alone, lingering phage resistors, or a sublethal inoculum. In vitro phage-lysed bacteria provide partial protection, suggesting a combination of phage-induced lytic activity and immune stimulation by phage treatment is responsible for the effect. These observations imply certain phages may induce host adaptive responses following the lysis of the infecting bacteria. This work suggests phage therapy may contain a dual-action effect, an initial treatment efficacy followed by a long-term protection against reoccurring infection, a therapeutic-vaccination mechanism of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- TAILOR Labs, Baylor College of Medicine, Houston, TX 77030.
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030.
- Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, TX 77030.
ORCID-Profile: Yikun Xing, Haroldo J Hernandez Santos, Ling Qiu, Samantha R Ritter, Jacob J Zulk, Rachel Lahowetz, Kathryn A Patras, Austen L Terwilliger, Anthony W Maresso
Förderung
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- NIAID NIH HHS
- Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (Kleberg Foundation)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIDDK NIH HHS
Zitieren
APA
Xing, Y., Hernandez Santos, H. J., Qiu, L., Ritter, S. R., Zulk, J. J., Lahowetz, R., Patras, K. A., Terwilliger, A. L., & Maresso, A. W. (2025). Phage-induced protection against lethal bacterial reinfection. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2423286122
Vancouver
Xing Y, Hernandez Santos HJ, Qiu L, Ritter SR, Zulk JJ, Lahowetz R, et al. Phage-induced protection against lethal bacterial reinfection. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2423286122
BibTeX
@article{Xing2025,
author = {Xing, Yikun and Hernandez Santos, Haroldo J and Qiu, Ling and Ritter, Samantha R and Zulk, Jacob J and Lahowetz, Rachel and Patras, Kathryn A and Terwilliger, Austen L and Maresso, Anthony W},
title = {Phage-induced protection against lethal bacterial reinfection},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2423286122}
}
EUVIMED